Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
59.17
+0.20 (0.34%)
At close: Apr 25, 2025, 4:00 PM
59.25
+0.08 (0.14%)
After-hours: Apr 25, 2025, 5:13 PM EDT
Incyte Market Cap
Incyte has a market cap or net worth of $11.45 billion as of April 25, 2025. Its market cap has decreased by -7.79% in one year.
Market Cap
11.45B
Enterprise Value
9.35B
1-Year Change
-7.79%
Ranking
Category
Stock Price
$59.17
Market Cap Chart
Since December 1, 1998, Incyte's market cap has increased from $887.90M to $11.45B, an increase of 1,189.44%. That is a compound annual growth rate of 10.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 11.41B | -14.24% |
| Dec 31, 2024 | 13.31B | -5.44% |
| Dec 29, 2023 | 14.07B | -21.25% |
| Dec 30, 2022 | 17.87B | 10.21% |
| Dec 31, 2021 | 16.21B | -14.88% |
| Dec 31, 2020 | 19.05B | 1.27% |
| Dec 31, 2019 | 18.81B | 38.99% |
| Dec 31, 2018 | 13.53B | -32.29% |
| Dec 29, 2017 | 19.99B | 5.81% |
| Dec 30, 2016 | 18.89B | -6.36% |
| Dec 31, 2015 | 20.17B | 63.32% |
| Dec 31, 2014 | 12.35B | 51.41% |
| Dec 31, 2013 | 8.16B | 274.30% |
| Dec 31, 2012 | 2.18B | 14.96% |
| Dec 30, 2011 | 1.90B | -7.01% |
| Dec 31, 2010 | 2.04B | 88.80% |
| Dec 31, 2009 | 1.08B | 193.21% |
| Dec 31, 2008 | 368.30M | -56.50% |
| Dec 31, 2007 | 846.70M | 72.90% |
| Dec 29, 2006 | 489.70M | 9.92% |
| Dec 30, 2005 | 445.50M | -39.62% |
| Dec 31, 2004 | 737.80M | 48.87% |
| Dec 31, 2003 | 495.60M | 59.97% |
| Dec 31, 2002 | 309.80M | -76.00% |
| Dec 31, 2001 | 1.29B | -19.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 768.05B |
| UnitedHealth Group | 387.43B |
| Johnson & Johnson | 371.35B |
| AbbVie | 317.67B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.91B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |